Proving Scientific Dogma Isn’t the Whole Story

Pittsburgh, Pennsylvania (PRWEB) April 13, 2015 A serendipitous combination of technology and scientific discovery, coupled with a hunch, allowed University of Pittsburgh Cancer Institute (UPCI) researchers to reveal a previously invisible biological process that may be implicated in the rapid growth of some cancers. The project, funded by the National Institutes of Health (NIH), ...

Chromosome Microarrays Proving to be a Hit in the Early Diagnosis of Autism Spectrum Disorder

Chromosome Microarrays Proving to be a Hit in the Early Diagnosis of Autism Spectrum Disorder
Wellesley, Mass. (PRWEB) April 29, 2015 BCC Research (http://www.bccresearch.com) reveals in its new report on Autism Spectrum Disorder (ASD), in 2013 the global markets were valued at approximately $ 346.2 million. The global therapeutics market for ASD accrued $ 305 million in 2013, while the global diagnostics market accrued $ 41.2 million. In 2014, the ...

Biological Therapies in Cancer Treatment to Reach $66 Billion in 2019; Biosimilars Proving to be a Major Driving Factor

Biological Therapies in Cancer Treatment to Reach $66 Billion in 2019; Biosimilars Proving to be a Major Driving Factor
Wellesley, Mass. (PRWEB) March 24, 2015 Wellesley, Mass., March 24, 2015 – BCC Research (http://www.bccresearch.com) reveals in its new report on biologic cancer treatment that access and affordability of cancer treatment options in various countries, along with a rise in the number of cancer incidences due to better diagnostic approaches, will stimulate growth in the ...

Biological Therapies in Cancer Treatment to Reach $66 Billion in 2019; Biosimilars Proving to be a Major Driving Factor

Biological Therapies in Cancer Treatment to Reach $66 Billion in 2019; Biosimilars Proving to be a Major Driving Factor
Wellesley, Mass. (PRWEB) March 24, 2015 Wellesley, Mass., March 24, 2015 – BCC Research (http://www.bccresearch.com) reveals in its new report on biologic cancer treatment that access and affordability of cancer treatment options in various countries, along with a rise in the number of cancer incidences due to better diagnostic approaches, will stimulate growth in the ...